12:00 AM
 | 
Aug 08, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Amgen, Kyowa Hakko Kirin sales and marketing update

Kyowa disclosed in its 1H11 earnings that in April it launched Romiplate romiplostim in Japan to treat chronic idiopathic thrombocytopenic...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >